Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome

Rheumatology International

Volumn 30, Issue 6, 2010, Pages 841-846

  Rigante, Donato ^a   Valentini, Piero ^a   Rizzo, Daniela ^a   Leo, Andrea ^a   De Rosa, Gabriella ^a   Onesimo, Roberta ^a   De Nisco, Alessia ^a   Angelone, Donatella Francesca ^a   Compagnone, Adele ^a   Delogu, Angelica Bibiana ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Coronary artery abnormalities; Intravenous immunoglobulins; Kawasaki syndrome

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; HEMOGLOBIN; IMMUNOGLOBULIN;

ARTICLE; CERVICAL LYMPHADENOPATHY; CHILD; CLINICAL ARTICLE; CONJUNCTIVITIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE DURATION; DRUG MEGADOSE; DRUG RESPONSE; ECHOCARDIOGRAPHY; ERYTHEMA; FEMALE; FEVER; HUMAN; INCIDENCE; LENGTH OF STAY; LEUKOCYTE COUNT; LOW DRUG DOSE; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEUTROPHIL COUNT; ONSET AGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT;

ASPIRIN; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMORBIDITY; CORONARY ARTERY DISEASE; DRUG RESISTANCE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFANT, NEWBORN; ITALY; MALE; MONITORING, PHYSIOLOGIC; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 77951025715     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1337-1     Document Type: Article

References (28)

1. Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 16:178-222
2. Burns JC (2002) Commentary: translation of Dr. Tomisaku Kawasaki's original report of fifty patients in 1967. Pediatr Infect Dis J 21:993-1005
3. Burns JC (2004) Kawasaki syndrome. Lancet 364:533-544
4. Holman RC, Curns AT, Belay ED, Steiner CA, Schonberger LB (2003) Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 112:495-501
5. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P (2006) EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65:936-941
6. Satou GM, Giamelli J, Gewitz MH (2007) Kawasaki disease: diagnosis, management and long-term implications. Cardiol Rev 15:163-169
7. Dajani AS, Taubert KA, Takahashi M, Bierman FZ, Freed MD, Ferrieri P, Gerber M, Shulman ST, Karchmer AW, Wilson W (1994) Guidelines for long-term management of patients with Kawasaki disease: report from the Committee on rheumatic fever, endocarditis and Kawasaki disease, Council on cardiovascular disease in the young, American Heart Association. Circulation 89:916-922
8. Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A (2006) Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113:2606-2612
9. De Rosa G, Pardeo M, Rigante D (2007) Current recommendations for the pharmacological therapy in Kawasaki syndrome and management of its cardiovascular complications. Eur Rev Med Pharmacol Sci 11:301-308
10. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341-347
11. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633-1639
12. Wallace CA, French JW, Kahn SJ, Sherry DD (2000) Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 105:E78
13. Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, Matsuishi T (2006) Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 149:237-240
14. Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K, Kogaki S, Hara J (2007) Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 166:131-137
15. Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C (2003) Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 24:145-148
16. Kim T, Choi W, Woo CW, Choi B, Lee J, Lee K, Son C, Lee J (2007) Predictive risk factors for coronary artery abnormalities in Kawasaki disease. Eur J Pediatr 166:421-425
17. Nakamura Y, Yashiro M, Uehara R, Oki I, Watanabe M, Yanagawa H (2008) Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005-2006. J Epidemiol 18:167-172
18. Yeo Y, Kim T, Ha K, Jang G, Lee J, Lee K, Son C, Lee J (2009) Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor. Eur J Pediatr 168:157-162
19. Huang WC, Huang LM, Chang IS, Chang LY, Chiang BL, Chen PJ, Wu MH, Lue HC, Lee CY, Kawasaki Disease Research Group (2009) Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics 123:e401-e405
20. Kato S, Kimura M, Tsuji K, Kusakawa S, Asai T, Juji T, Kawasaki T (1978) HLA antigens in Kawasaki disease. Pediatrics 61:252-255
21. Lin YJ, Wan L, Wu JY, Sheu JJ, Lin CW, Lan YC, Lai CH, Hung CH, Tsai Y, Tsai CH, Lin TH, Lin JG, Hsueh KC, Huang YM, Chang JS, Tsai FJ (2009) HLA-E gene polymorphism associated with susceptibility to Kawasaki disease and formation of coronary artery aneurysms. Arthritis Rheum 60:604-610
22. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association, American Academy of Pediatrics (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110:2747-2771
23. Baer AZ, Rubin LG, Shapiro CA, Sood SK, Rajan S, Shapir Y, Romano A, Bierman FZ (2006) Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome. Arch Pediatr Adolesc Med 160:686-690
24. Research Committee on Kawasaki disease (1984) Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Japanese Ministry of Health and Welfare, Tokyo, Japan
25. Capannari TE, Daniels SR, Meyer RA, Schwartz DC, Kaplan S (1986) Sensitivity, specificity and predictive value of twodimensional echocardiography in detecting coronary artery aneurysms in patients with Kawasaki disease. J Am Coll Cardiol 7:355-360
26. de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW (1998) Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 133:254-258
27. McCrindle BW, Li JS, Minich LA, Colan SD, Atz AM, Takahashi M, Vetter VL, Gersony WM, Mitchell PD, Newburger JW (2007) Coronary artery involvement in children with Kawasaki disease. Risk factors from analysis of serial normalized measurements. Circulation 116:174-179
28. Furuyama H, Odagawa Y, Katoh C, Iwado Y, Ito Y, Noriyasu K, Mabuchi M, Yoshinaga K, Kuge Y, Kobayashi K, Tamaki N (2003) Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J Pediatr 142:149-154